Key Personnel Sung Ho Hahm, Ph.D. President, C.E.O.   Dr. Hahm is the founder and currently serves as the company's President and Chief Executive Officer. Trained as a molecular neuroscientist, Dr. Hahm has more than 20 years of experience. He obtained his Bachelor’s degree from Seoul National University and received his Post-graduate Diploma from Massey University in New Zealand. He finished his Master of Science degree from the University of South Florida and then his Ph. D. degree in biomedical science from the University of South Carolina in 1994. He worked as a Visiting Fellow and then as a Staff Fellow at the National Institute of Mental Health between 1994 and 2000, conducting key studies involving molecular mechanism of neuroblastoma cancer development. He also worked at Johns Hopkins University as a research faculty, responsible for molecular studies of prostate cancer progression and for the development of bioinformatics tools. Dr. Hahm has been involved in the establishment of two other start-up biotech companies as a founding member during the past five years. Hyun Hee Kim, Ph.D. Scientist   Dr. Kim obtained Bachelor of Science in Molecular Biology from Pusan National University, and a Master of Medicine in Molecular Pharmacology from the Pusan National University, College of Medicine. She obtained Ph.D. degree in Anatomy and Neurobiology at the University Of Maryland, School of Medicine in 2006. Before starting her Ph.D. study, Dr. Kim worked as a government supported intern at the Laboratory for Advanced Biotechnology and Biomedical Instrumentation in Pohang University of Science and Technology. Dr. Kim also worked in the MEMS laboratory in Samsung Advanced Institute of Technology in Korea, and was involved the development of chip-based micro PCR device. MiSook Choe, M.S. Associate Scientist   Ms. Choe obtained Master of Science degree in Biochemistry from the Gyeongsang National University in Korea. She has also completed two years of course work in molecular biology as a Ph.D. student at the same institution. She has a broad experience in molecular biology and biochemistry starting from a routine DNA, RNA, or protein work extending to studies involving transgenic plants. Jiho Joung, B.S. Consulting Contractor   Mr. Joung obtained Bachelor of Science degree in Computer Engineering from Hongik University in Korea. He is currently working as Information Systems Manager at TissueGene, Inc. He has over ten years of experience in information technology field, and his previous positions include Systems Manager at Kolon Life Science, Inc. and Programmer/Consultant at MBIM Management Systems, Inc. Mr. Joung is responsible for building infrastructure for Promogen’s IT network, as well as the development and implementation of bioinformatics tools. These tools will serve for the purpose of handling and streamlining information generated from expression profiling of human tissue samples and other data generated using these tissue samples. Board of Directors Sung Ho Hahm, Ph.D. Chairman of the Board   Dr. Hahm is the founder and currently serves as the company's President and Chief Executive Officer. Trained as a molecular neuroscientist, Dr. Hahm has more than 20 years of experience. He obtained his Bachelor’s degree from Seoul National University and received his Post-graduate Diploma from Massey University in New Zealand. He finished his Master of Science degree from the University of South Florida and then his Ph. D. degree in biomedical science from the University of South Carolina in 1994. He worked as a Visiting Fellow and then as a Staff Fellow at the National Institute of Mental Health between 1994 and 2000, conducting key studies involving molecular mechanism of neuroblastoma cancer development. He also worked at Johns Hopkins University as a research faculty, responsible for molecular studies of prostate cancer progression and for the development of bioinformatics tools. Dr. Hahm has been involved in the establishment of two other start-up biotech companies as a founding member during the past five years. Sang Min Lee Board Member   Mr. Lee is the President and Chief Executive Officer of Daeho AL Co., Ltd., which is engaged in manufacturing rolled, drawn, and folded products of aluminum. With 154 employees currently working for the company, Daeho AL’s annual sales for the year 2005 was close to U$100M. In order to take Daeho AL to the next level of leadership, Mr. Lee aspires to expand his business into the biotech and biopharmaceutical field applying cutting edge technologies. Kwan H. Lee, M.D., Ph.D. Board Member   Dr. Lee is trained as an orthopedic surgeon with approximately 20 years of experience. He serves as TissueGene’s President and Chief Executive Officer. Dr. Lee is a well-known leader in the field of orthopedic medicine. He has served as a professor and the Director of the Clinical Research Center of Inha University Hospital in Korea. He is a member of the Gene Therapy Committee of the Korean FDA, which has provided him unique experience in understanding the drug evaluation and approval processes in connection with genetic therapies such as TissueGene's own cell-mediated technology. Business Advisors Roger Kang     Mr. Kang is currently serving as Promogen’s Secretary and Treasurer. Mr. Kang is providing general assistance for Promogen’s operation. Mr. Kang also works as a Chief Operating Officer at TissueGene, Inc. Before joining TissueGene, he was the Managing Director of Trioh Corporation in New Jersey, a company that specializes in international sales of medical devices and equipment. At Trioh, Mr. Kang was primarily responsibile for corporate operations and the development of sales channels for products. Mr. Kang has over 17 years of experience, eleven of which has been in the life sciences field. J. Kelly Ganjei     With his experience as the Vice President in Business Development at TissueGene, Mr. Ganjei not only facilitates Promogen’s business development, but he is also involved in setting up the company’s IT infrastructure. Mr. Ganjei holds a degree in Microbiology, and his scientific research spans the fields of molecular neurobiology and human genetics. He continues to study in the fields of enterprise infrastructure design, bioinformatics, and business. At TissueGene, he set up an informatics infrastruture to support the global network of the TissueGene research team. Copyright © 2006 Promogen, Inc. All Rrights Reserved.